At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 327 enrolled
Drug / intervention
DS107 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Double-blind, Vehicle-Controlled, Phase IIb Study to Assess the Efficacy and Safety of Topically Applied DS107 Cream to Adults With Mild to Moderate Atopic Dermatitis
In Brief
A Phase 2 clinical trial evaluating DS107 and Vehicle cream for Atopic Dermatitis. Completed, enrolled 327 participants across 3 sites in 3 countries.
Detailed Summary
The purpose of this randomized, double blind, placebo controlled, parallel group study is to compare the safety and efficacy of topically applied DS107 cream (1% and 5%) versus vehicle cream, in the treatment of adult patients with mild to moderate Atopic Dermatitis (AD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
CountriesCanada, South Africa, United States
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedOct 2016
Enrollment StartDec 2016
Primary CompletionJul 2018
TodayJul 2026
First PostedOct 6, 2016
Enrollment StartDec 1, 2016
Primary CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 9.7 years ago
Interventions
DS107drug
Vehicle creamother